Performance of Facial Dysmorphology Novel Analysis: comparison to molecular testing-based diagnostics

October 21, 2015

During the ASGH15 Conference in Baltimore, MD, USA.L. this poster was presented by Basel-Vanagaite , S. Lyonnet, V. Cormier-Daire, M. Rio, J. Amiel, L. Wolf.

331 frontal images of Caucasian children with 43 different molecularly confirmed syndromes were analyzed. The molecularly confirmed diagnosis was listed in the first 20 matches for 89% of the cases, 10 for 75% of the cases, 5 for 69% of the cases, 2 for 54% of the cases and as the first result for 40% of the cases (Figure 2). Statistically, the chances of obtaining such results are virtually zero (p<1e-100). However, since some syndromes are more common than others, we ran permutation tests. Mixing the images and the diagnosis randomly, the rank 1 retrieval is less than 5%. The best results were observed for SHORT Syndrome, Kaufman Oculocerebrofacial Syndrome and Auriculo-condylar Syndrome 1 (100% correct 1st match). For microdeletion syndromes, the best performance was observed for Angelman Syndrome (listed in the first 5 matches in 93% of the cases) as compared to Williams Syndrome and 22q11.2 Syndrome (86% and 67%, respectively.). The team concluded that a system supported with FDNA technology can be useful for medical professionals researching and investigating genetic syndromes. Future applications include its usage to:1)guide targeted molecular testing; 2)complement next-generation sequencing-based molecular testing by inferring causative genetic variants from sequencing data.

Related articles

Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading
Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

In a recent landmark scientific webinar trailblazing development in dermatological phenotyping, genetic disorders, and the transformative application of artificial intelligence (AI) in rare disease diagnostics in Italy were explored. The event convened leading experts, researchers, and clinicians, who unveiled their experience in the clinic, including the innovative use of an AI-powered called Face2Gene to significantly […]

Continue reading